FDA approves new drug to treat HIV infection
The U.S. Food and Drug Administration has approved Tivicay (dolutegravir), a new drug to treat HIV-1 infection. Tivicay is an ...
The U.S. Food and Drug Administration has approved Tivicay (dolutegravir), a new drug to treat HIV-1 infection. Tivicay is an ...
Chemically modified inhibitors of the COX-2 enzyme relieve anxiety behaviors in mice by activating natural "endocannabinoids" without gastrointestinal side effects, ...
Small proteins called peptides that consist of 10 to 50 amino acids are being studied as cancer vaccines and as ...
A team of University of California, San Diego researchers has designed new compounds that mimic those naturally used by the ...
New research conducted by Harvard scientists is laying out a road map to one of the holy grails of modern ...
Physicians and patients who are wary of addiction to pain medication and opioids may soon have a healthier and more ...
The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, took action this week against ...
The U.S. Food and Drug Administration announced that the U.S. is now a "listed" countrydisclaimer icon with the European Commission ...
Aspirin is known to lower risk for some cancers, and a new study led by a UC San Francisco scientist ...
A phase 1 clinical trial for the first treatment to reset the immune system of multiple sclerosis (MS) patients showed ...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
